Standard Operating Procedure for Stability Indicating Method Development in Analytical Laboratories

1. Purpose

This SOP defines the structured process for the development of stability indicating analytical methods capable of distinguishing the active pharmaceutical ingredient (API) from its degradation products. These methods are essential to ensure drug safety, efficacy, and regulatory compliance over shelf-life.

2. Scope

This SOP applies to all stability indicating assay method development and validation activities performed in the Analytical Method Development (AMD) department for both API and finished dosage forms intended for regulatory submission and ongoing stability studies.

3. Responsibilities

• Analyst: Performs forced degradation studies, develops the chromatographic method, and documents procedures and results.
• Method Development Scientist: Designs method development strategy and oversees system optimization.
• QA Personnel: Reviews documentation, ensures GDP compliance, and approves method reports.
• Validation Team: Validates the developed method as per ICH guidelines.

4. Accountability

The Head of Analytical Method Development is accountable for the scientific integrity, compliance, and regulatory suitability of all stability indicating methods developed under this SOP.

5. Procedure

5.1 Pre-requisite Evaluation

1. Review API structure, known degradation pathways, and prior analytical data if available.
2. Define method objective: assay, related substances, impurity profiling, etc.
3. Procure qualified reference standards and required reagents with COA.

5.2 Forced Degradation Studies

1. Subject API and/or formulation to stress conditions as per ICH Q1A (R2):
• Thermal (60°C or higher)
• Photolytic (UV 254/366 nm)
• Acid/base hydrolysis (0.1N HCl/NaOH)
• Oxidative degradation (3-6% H₂O₂)
• Humidity (75% RH)
2. Collect time-point samples and store under controlled conditions.
3. Analyze to determine degradant profile and extent of degradation.

5.3 Chromatographic Method Development

1. Select appropriate technique: HPLC/UPLC with UV/PDA/ELSD detectors.
2. Evaluate various stationary phases (e.g., C8, C18, Phenyl) and mobile phase systems (buffered aqueous + organic solvents).
3. Optimize method for resolution (Rs > 2) between API and all degradants.
4. Ensure peak purity using PDA and system suitability compliance.
5. Perform specificity test to confirm separation from placebo and excipients.

5.4 Method Optimization

1. Optimize key parameters: flow rate, injection volume, pH, gradient profile, and detection wavelength.
2. Demonstrate method reproducibility and robustness under variable conditions.

5.5 Documentation

1. Prepare detailed method development summary including:
   • Objective
   • Forced degradation results
   • Chromatographic conditions
   • Optimization rationale
2. Attach representative chromatograms, peak purity reports, and degradation profiles.

5.6 Validation

1. Submit the method for validation as per ICH Q2(R1): specificity, accuracy, precision, linearity, range, robustness, LOD, LOQ.
2. Maintain validation protocol and summary report in validated templates (see Annexures).

6. Abbreviations

• API: Active Pharmaceutical Ingredient
• PDA: Photodiode Array
• LOD: Limit of Detection
• LOQ: Limit of Quantitation
• HPLC: High-Performance Liquid Chromatography

7. Documents

1. Method Development Worksheet – Annexure-1
2. Forced Degradation Summary Template – Annexure-2
3. Chromatographic Condition Log Sheet – Annexure-3
4. Validation Protocol Template – Annexure-4

8. References

• ICH Q1A(R2) – Stability Testing of New Drug Substances
• ICH Q2(R1) – Validation of Analytical Procedures
• WHO TRS 1010 Annex 4 – Development of Stability Indicating Methods
• FDA Guidance for Industry – Analytical Procedures and Methods Validation

9. SOP Version

Version: 2.0

10. Approval Section

11. Annexures

Annexure-1: Method Development Worksheet

Includes input sections for objective, trial parameters, results, observations, chromatographic systems, peak evaluation, and resolution factors.

Annexure-2: Forced Degradation Summary Template

Annexure-3: Chromatographic Condition Log Sheet

Records buffer composition, pH, solvent ratio, column type, flow rate, detection wavelength, and run time for each successful trial.

Annexure-4: Validation Protocol Template

Structured format including validation parameters, criteria, sample preparation strategy, number of replicates, acceptance criteria, and summary template.

Revision History:

Standard Operating Procedure for Documentation of Analytical Calculations and Worksheets in Analytical Method Development

1. Purpose

This SOP defines the procedure for recording analytical calculations and completing raw data worksheets to ensure data accuracy, traceability, and compliance with Good Documentation Practices (GDP) during Analytical Method Development (AMD).

2. Scope

This SOP applies to all analytical calculations and worksheets generated during the development, optimization, verification, and validation of analytical methods in the AMD department.

3. Responsibilities

• Analyst: Accurately documents calculations and raw data on pre-approved formats.
• Reviewer: Verifies all entries and calculations for correctness and compliance.
• QA Personnel: Audits documentation for adherence to GDP and internal SOPs.

4. Accountability

The Head of AMD is accountable for the integrity, review, and archival of all analytical worksheets and calculations maintained under this SOP.

5. Procedure

5.1 Preparation of Analytical Worksheets

1. Use only controlled and numbered worksheets issued by the QA department (refer Annexure-1).
2. Enter the study ID, method number, analyst name, and date at the top of the sheet.
3. Fill in test conditions, sample details, instrument ID, and analysis date.

5.2 Documentation of Raw Data

1. Record all raw data (e.g., weights, volumes, instrument readings) in blue/black indelible ink.
2. Do not overwrite; strike through incorrect entries with a single line, write correct data nearby, and initial/date the correction.
3. Attach printouts (chromatograms, spectra, etc.) with analyst signature and date on each page.

5.3 Calculations and Formula Usage

1. Use approved formulae specified in the test method.
2. Show all steps of calculations including units (e.g., mg/mL, %, ppm).
3. Include dilution factors, purity corrections, and standardization values where applicable.
4. Round off values as per SOP on significant figures (refer SOP/AMD/212/2025).

5.4 Review and Cross-Verification

1. Second analyst or reviewer must cross-check 100% of calculations.
2. Reviewer to initial and date the reviewed pages after verification.
3. Any discrepancy must be investigated and documented with appropriate justification.

5.5 Archival of Worksheets

1. After QA review, compile the complete set of worksheets and associated data in a labeled folder.
2. Archive as per document control SOP (SOP/QA/001/2025) in the AMD record room.
3. Retain all documentation for a minimum period of five years or as per regulatory requirement.

6. Abbreviations

• AMD: Analytical Method Development
• GDP: Good Documentation Practices
• QA: Quality Assurance
• ID: Identification

7. Documents

1. Controlled Worksheet Template – Annexure-1
2. Calculation Formula Sheet – Annexure-2
3. Reviewer Checklist – Annexure-3

8. References

• ICH Q10 – Pharmaceutical Quality System
• WHO TRS 986 Annex 3 – GMP for Pharmaceuticals
• FDA 21 CFR Part 211 – cGMP Requirements
• SOP/AMD/212/2025 – Guidelines on Rounding and Significant Figures

9. SOP Version

Version: 2.0

10. Approval Section

11. Annexures

Annexure-1: Controlled Worksheet Template

Includes fields for test ID, method title, equipment ID, sample ID, dilution factors, raw data, and calculation steps.

Annexure-2: Calculation Formula Sheet

Annexure-3: Reviewer Checklist

• Worksheet signed and dated by analyst
• All calculations verified
• Corrections compliant with GDP
• Attached chromatograms, spectra, instrument logs

Revision History:

Standard Operating Procedure for Qualification of Reference Standards and Working Standards in Analytical Method Development

1. Purpose

To lay down a procedure for the qualification, labeling, documentation, usage, and storage of pharmacopoeial reference standards (RS) and secondary working standards (WS) used in the Analytical Method Development (AMD) department.

2. Scope

This SOP applies to all AMD personnel responsible for procuring, qualifying, using, and maintaining records related to reference and working standards within the pharmaceutical analytical laboratory.

3. Responsibilities

• Analyst: Handles and maintains the integrity of RS and WS during analytical activities.
• AMD Supervisor: Ensures compliance with qualification and documentation procedures.
• QA Department: Verifies and audits standard qualification activities.

4. Accountability

The Head of Analytical Method Development is accountable for ensuring the proper qualification, usage, and control of all standards used in analytical testing and method development.

5. Procedure

5.1 Procurement of Reference Standards

1. Purchase RS from recognized sources such as USP, EP, BP, IP, or WHO reference standards.
2. Verify certificate of analysis (CoA), lot number, and expiry date upon receipt.
3. Log the RS in the Reference Standard Register (Annexure-1).

5.2 Qualification of Working Standards

1. Select RS for the qualification of WS.
2. Perform identity, assay, and impurity profiling on three replicate preparations.
3. Calculate assigned potency of WS based on assay result relative to RS.
4. Document all qualification results and assign a unique WS code (Annexure-2).

5.3 Labeling

1. Affix label to RS and WS containers indicating:
   • Name of substance
   • Assigned potency (for WS)
   • Batch/Lot number
   • Qualification date
   • Expiry date
   • Storage condition

5.4 Storage

1. Store standards in designated desiccators or refrigerators as per CoA/storage conditions.
2. Restrict access to authorized personnel only.
3. Maintain temperature log for the storage area.

5.5 Usage

1. Withdraw minimal quantity required using a clean spatula or scoop.
2. Record each usage in the WS/RS usage log (Annexure-3).
3. Avoid contamination during withdrawal; do not return excess material to the original container.

5.6 Requalification and Expiry

1. Assign requalification period for WS (e.g., 6 months) based on stability data.
2. Before expiry, evaluate WS potency and assign new qualification if applicable.
3. Destroy expired standards as per the destruction SOP and document appropriately.

6. Abbreviations

• RS: Reference Standard
• WS: Working Standard
• AMD: Analytical Method Development
• CoA: Certificate of Analysis

7. Documents

1. Reference Standard Register – Annexure-1
2. Working Standard Qualification Record – Annexure-2
3. RS/WS Usage Log – Annexure-3

8. References

• ICH Q6A – Specifications: Test Procedures and Acceptance Criteria
• USP General Chapter <1058> Analytical Instrument Qualification
• WHO Guidelines on Quality Control of Pharmaceutical Products

9. SOP Version

Version: 2.0

10. Approval Section

11. Annexures

Annexure-1: Reference Standard Register

Annexure-2: Working Standard Qualification Record

Includes detailed assay results, comparison with RS, chromatograms, calculation of assigned potency, analyst and reviewer initials.

Annexure-3: RS/WS Usage Log

Revision History:

Standard Operating Procedure for Handling and Documentation of Raw Analytical Data in Analytical Method Development

1. Purpose

The purpose of this SOP is to define the standardized procedure for the proper handling, documentation, review, and archiving of raw analytical data generated during method development activities. It ensures traceability, transparency, and data integrity in compliance with ALCOA+ principles, GMP, and regulatory standards.

2. Scope

This SOP applies to all personnel involved in generating or reviewing raw analytical data within the Analytical Method Development (AMD) laboratory, including internal staff and contract resources. It covers both manually recorded and electronically generated data.

3. Responsibilities

• Analysts: Record all raw data promptly, clearly, and accurately during experimental work. Submit raw data for review without delay.
• Supervisors: Review and approve raw data, verify compliance with SOPs and protocols, and ensure data completeness.
• QA Personnel: Periodically audit raw data handling processes and provide compliance feedback to the AMD head.

4. Accountability

The Head of the AMD department is accountable for ensuring that raw data handling and documentation procedures are implemented consistently and effectively throughout the laboratory. The QA department is accountable for oversight and compliance monitoring.

5. Procedure

5.1 Definition of Raw Data

1. Raw data includes original records and documentation resulting from analytical testing, including:
   • Instrument printouts
   • Chromatograms
   • Spectra
   • Balance printouts
   • Calculation sheets
   • Lab notebook entries

5.2 Recording of Raw Data

1. All raw data must be recorded at the time of activity using indelible ink or in validated electronic systems.
2. Each data entry must include the date, analyst’s initials, and instrument/equipment identification.
3. Manual calculations must be legibly written and verified by a second individual.

5.3 Handling Electronic Raw Data

1. Ensure data is saved in the designated secured server folder with appropriate naming conventions.
2. Audit trails must remain enabled in all computerized systems used for data acquisition.
3. No overwriting of data is permitted; any corrections must be documented separately with justification and approval.

5.4 Corrections and Annotations

1. If a mistake is identified:
   • Strike through with a single line, retain the original data
   • Write corrected data nearby with initials, date, and justification
2. Electronic data corrections must follow the same logic with audit trail justification.

5.5 Review and Verification

1. Supervisors must review raw data within 5 working days of its generation.
2. Review includes:
   • Completeness of data sets
   • Legibility of entries
   • Verification of calculations
   • Assessment of any deviations or unexpected observations

5.6 Archival of Raw Data

1. Upon review, raw data must be signed, dated, and submitted to the Documentation Officer for archival.
2. Data shall be stored in fire-proof cabinets (physical) or secure validated servers (electronic).
3. Maintain an index of raw data with document number, analyst name, and storage location (Annexure-1).

5.7 Data Integrity Monitoring

1. Periodic QA audits shall focus on:
   • Completeness of raw data
   • Legibility and attribution
   • Compliance with ALCOA+ principles

6. Abbreviations

• AMD: Analytical Method Development
• ALCOA+: Attributable, Legible, Contemporaneous, Original, Accurate + Complete, Consistent, Enduring, Available
• QA: Quality Assurance

7. Documents

1. Raw Data Index Log – Annexure-1
2. Raw Data Checklist – Annexure-2

8. References

• 21 CFR Part 11 – Electronic Records and Electronic Signatures
• ICH Q9 – Quality Risk Management
• WHO TRS 996 Annex 5 – Good Data Management Practices

9. SOP Version

Version: 2.0

10. Approval Section

11. Annexures

Annexure-1: Raw Data Index Log

Annexure-2: Raw Data Review Checklist

Revision History:

Standard Operating Procedure for Documentation Practices in Laboratory Notebooks in Analytical Method Development

1. Purpose

The purpose of this SOP is to establish clear guidelines for documenting scientific work, including observations, calculations, and results in laboratory notebooks within the Analytical Method Development (AMD) department. This ensures data integrity, traceability, and compliance with current regulatory standards such as ALCOA+ and Good Laboratory Practices (GLP).

2. Scope

This SOP applies to all analysts, scientists, and contract personnel working in the AMD laboratory who are responsible for generating, recording, or reviewing experimental data and activities in laboratory notebooks (paper or electronic).

3. Responsibilities

• Analysts: Record all experimental work in a clear, legible, and chronological manner.
• Supervisors/Group Leaders: Review and sign completed entries and ensure timely documentation practices are followed.
• QA Personnel: Conduct periodic audits to ensure notebooks meet compliance and data integrity requirements.

4. Accountability

The Head of AMD is accountable for implementation, training, and adherence to documentation practices outlined in this SOP. QA Head is accountable for oversight and periodic review of documentation compliance.

5. Procedure

5.1 Notebook Allocation and Identification

1. Each analyst will be assigned a uniquely numbered laboratory notebook.
2. Record the following on the front cover:
   • Name of the Analyst
   • Department
   • Notebook Number
   • Start and End Date
3. Issue and return of notebooks shall be tracked by the AMD Documentation Officer using Annexure-1.

5.2 Documentation Guidelines

1. Write entries using a permanent ink pen (blue or black). Do not use pencils or erasable ink.
2. Each page must be numbered sequentially and entries must be dated.
3. Start each new experiment on a new page and provide a meaningful title.
4. Record the objective, materials, procedure, observations, calculations, and results.
5. Any graphs or printouts must be glued securely and signed across the pasted portion.

5.3 Corrections and Deviations

1. Do not use correction fluid, erasers, or overwrite data.
2. For corrections, strike through the incorrect entry with a single line, write the correct data next to it, and sign with date and initials.
3. Deviations from procedure must be recorded and justified clearly.

5.4 Signature and Review

1. Each entry must be signed and dated by the analyst upon completion.
2. Reviewer (Group Leader or Supervisor) must review and countersign within 5 working days.
3. Comments by the reviewer must be dated and documented next to the reviewed content.

5.5 Closure of Notebook

1. Upon completion, the notebook shall be closed with a summary and date of closure.
2. QA or Documentation Officer shall verify completeness before archiving.
3. Notebook status is updated in Annexure-1 record sheet.

5.6 Electronic Laboratory Notebooks (ELN)

1. If used, ELNs must be validated systems compliant with 21 CFR Part 11.
2. User access control, audit trails, and backup mechanisms must be enabled.
3. Follow same documentation principles as physical notebooks.

6. Abbreviations

• AMD: Analytical Method Development
• ALCOA+: Attributable, Legible, Contemporaneous, Original, Accurate + Complete, Consistent, Enduring, Available
• ELN: Electronic Laboratory Notebook
• GLP: Good Laboratory Practices

7. Documents

1. Notebook Issue and Return Register – Annexure-1
2. Notebook Review Checklist – Annexure-2

8. References

• ICH Q10 – Pharmaceutical Quality System
• 21 CFR Part 11 – Electronic Records, Electronic Signatures
• WHO TRS 996 Annex 5 – Guidance on Good Data and Record Management Practices

9. SOP Version

Version: 2.0

10. Approval Section

11. Annexures

Annexure-1: Notebook Issue and Return Register

Annexure-2: Notebook Review Checklist

Revision History:

Standard Operating Procedure for Qualification and Verification of Weighing Balances in Analytical Method Development

1. Purpose

The purpose of this SOP is to define the procedure for the qualification (IQ, OQ, PQ) and routine verification of analytical weighing balances used in the Analytical Method Development laboratory. This ensures that all balances meet regulatory requirements and provide accurate and precise weighing results.

2. Scope

This SOP applies to all analytical balances, microbalances, and precision balances used for weighing raw materials, standards, samples, and reagents within the AMD department.

3. Responsibilities

• Analytical Personnel: Perform daily verification before use and document results appropriately.
• Engineering/Calibration Team: Conduct qualification and scheduled calibrations as per plan.
• QA: Review qualification documents and ensure compliance with calibration standards.

4. Accountability

The AMD Head and QA Head are accountable for ensuring that all balances in use are qualified, verified, and calibrated per this SOP and documented accordingly.

5. Procedure

5.1 Installation Qualification (IQ)

1. Ensure the balance is delivered with all accessories and documentation (user manual, calibration certificate, etc.).
2. Install the balance on a vibration-free surface in a designated weighing area with controlled environmental conditions.
3. Record environmental parameters (temperature, humidity, airflow) in Annexure-1.
4. Verify the availability of power supply and leveling of the instrument.

5.2 Operational Qualification (OQ)

1. Use certified standard weights (Class E2 or equivalent) for testing balance performance.
2. Perform accuracy, linearity, and repeatability tests as per Annexure-2.
3. Record observations for each parameter and compare against acceptance criteria.

5.3 Performance Qualification (PQ)

1. Conduct routine usage simulations with weights similar to actual laboratory use conditions.
2. Ensure consistent results for the same weights across multiple replicates.
3. Document PQ results in Annexure-3.

5.4 Daily Verification Procedure

1. Verify zero function and taring before each use.
2. Use standard weights (preferably mid-range of the balance capacity).
3. Document weight verification on Daily Balance Check Log (Annexure-4).
4. Do not use the balance if deviations exceed ±0.1% of the standard weight.

5.5 Calibration and Recalibration

1. Ensure external calibration is performed by a NABL-certified agency as per schedule.
2. Recalibration is triggered in cases of:
   • Balance relocation
   • Deviation or malfunction
   • After preventive maintenance

5.6 Handling Out-of-Tolerance Conditions

1. Stop using the balance immediately.
2. Quarantine and tag the instrument as “Out of Service.”
3. Report to Engineering and QA for investigation.
4. Perform impact assessment of previously weighed materials using the suspect balance.

6. Abbreviations

• IQ: Installation Qualification
• OQ: Operational Qualification
• PQ: Performance Qualification
• NABL: National Accreditation Board for Testing and Calibration Laboratories

7. Documents

1. IQ Checklist – Annexure-1
2. OQ Test Sheet – Annexure-2
3. PQ Validation Report – Annexure-3
4. Daily Verification Log – Annexure-4

8. References

• USP General Chapter <41> – Balances
• ICH Q9 – Quality Risk Management
• 21 CFR Part 211 – cGMP for Finished Pharmaceuticals

9. SOP Version

Version: 2.0

10. Approval Section

11. Annexures

Annexure-1: IQ Checklist

Annexure-2: OQ Test Sheet

Annexure-3: PQ Validation Report

Summary of balance performance with real sample weights during actual laboratory usage simulation across 5 replicates. Data falls within acceptance limits.

Annexure-4: Daily Balance Check Log

Revision History:

Standard Operating Procedure for Issuance and Control of Analytical Raw Data Sheets

1. Purpose

To establish a systematic procedure for the issuance and control of analytical raw data sheets used in Analytical Method Development (AMD) activities such as method development, validation, transfer, and routine analysis. This ensures accuracy, traceability, and regulatory compliance.

2. Scope

This SOP is applicable to all AMD personnel and QA personnel involved in the issuance, use, retrieval, and control of raw data sheets in the laboratory.

3. Responsibilities

• Analyst: Requests and uses data sheets appropriately, fills entries legibly, and submits them post-use for review.
• AMD Documentation Officer: Maintains logbooks, issues sheets with unique serial numbers, and archives used forms.
• QA Reviewer: Verifies correct usage and reviews completed raw data for integrity and completeness.

4. Accountability

The Head of Analytical Method Development is accountable for ensuring adherence to this SOP, and for safeguarding the integrity and traceability of raw analytical data sheets throughout their lifecycle.

5. Procedure

5.1 Format and Structure of Raw Data Sheets

1. Raw data sheets must be:
   • Pre-approved by QA
   • Assigned with unique serial numbers
   • Printed on official company letterhead or preformatted templates
2. Each sheet shall include:
   • Title and purpose
   • Reference SOP or protocol number
   • Section for date, analyst name, signature, and observations

5.2 Issuance of Raw Data Sheets

1. The AMD Documentation Officer maintains an issuance register (Annexure-1).
2. Sheets are issued only upon written/email request by the analyst with approval from Section Head.
3. Details such as SOP number, project name, analyst name, and number of sheets are recorded in the issuance register.

5.3 Usage Guidelines

1. Analysts must:
   • Fill entries in indelible ink
   • Correct errors by single-line strike-through with initials and date
   • Complete all fields; “NA” should be mentioned where not applicable
2. Each page must be numbered (e.g., Page 1 of 5) and signed by the analyst at the bottom.

5.4 Post-Use Handling and Review

1. Used sheets are submitted to AMD Reviewer for review.
2. QA performs a secondary check for:
   • Legibility and completeness
   • Consistency with instrument records
   • Adherence to ALCOA+ principles
3. Reviewed sheets are archived in the project-specific folder or validation dossier.

5.5 Control and Retention

1. All issued sheets (used or unused) are returned to Documentation Officer within 15 days.
2. Obsolete or damaged sheets are cancelled by marking “VOID” across the sheet and retained for record.
3. All records must be retained for a minimum of 5 years or as per regulatory/QA policy.

6. Abbreviations

• QA: Quality Assurance
• AMD: Analytical Method Development
• SOP: Standard Operating Procedure
• ALCOA: Attributable, Legible, Contemporaneous, Original, Accurate

7. Documents

1. Issuance Register – Annexure-1
2. Void Sheet Log – Annexure-2

8. References

• ICH Q9 – Quality Risk Management
• 21 CFR Part 211 – GMP for Finished Pharmaceuticals
• MHRA GxP Data Integrity Guidelines

9. SOP Version

Version: 2.0

10. Approval Section

11. Annexures

Annexure-1: Issuance Register

Annexure-2: Void Sheet Log

Revision History:

Standard Operating Procedure for Documentation Review Before Finalizing Analytical Reports

1. Purpose

This SOP describes the systematic approach to reviewing analytical documentation before finalizing and issuing reports. It ensures accuracy, traceability, data integrity, and compliance with regulatory expectations such as ICH, WHO, and 21 CFR Part 211.

2. Scope

This procedure applies to all analytical method development (AMD) personnel and QA reviewers involved in the evaluation of analytical data generated during development, validation, or transfer studies.

3. Responsibilities

• Analyst: Ensures that all data entries, observations, and calculations are complete, legible, and initialed.
• AMD Reviewer: Conducts comprehensive review of raw data, calculations, chromatograms, and logbook entries.
• QA Representative: Verifies compliance with data integrity principles, protocol requirements, and SOPs.

4. Accountability

The AMD Department Head is accountable for implementing this SOP and ensuring that no analytical report is finalized without documented evidence of prior data review and verification.

5. Procedure

5.1 Preparation for Documentation Review

1. Ensure that the analytical study is complete and all associated raw data is compiled.
2. Check inclusion of:
   • Sample preparation records
   • Instrument usage logs
   • System suitability data
   • Chromatograms with peak annotations
   • Calibration curves, calculations, and worksheets

5.2 Data Integrity and Compliance Verification

1. Verify ALCOA+ principles: Attributable, Legible, Contemporaneous, Original, Accurate, Complete, Consistent, Enduring, and Available.
2. Cross-check calculations using approved spreadsheet or manual formulas, as applicable.
3. Confirm that any corrections are GMP-compliant and justified.

5.3 Checklist-Based Review

1. Use Annexure-1: Pre-Report Review Checklist to confirm the presence and review of each required document and entry.
2. Note any missing or inconsistent data and return to the originating analyst for clarification or correction.

5.4 Critical Review Areas

• Ensure consistent sample identification numbers across all pages
• Review instrument printouts for alignment with reported results
• Evaluate chromatograms for baseline noise, peak resolution, retention time matching
• Ensure dilution factors and standard potency are correctly applied
• Confirm that specifications and acceptance criteria are referenced and met

5.5 Deviations and OOS/OOT Data Handling

1. Any Out-of-Specification (OOS) or Out-of-Trend (OOT) result must be reviewed as per SOP/QA/014/2025.
2. Document such cases using Annexure-2 and attach investigation summary if available.

5.6 Report Finalization and Approval

1. Upon successful review, sign the documentation review section on the report cover page.
2. Forward report for QA approval before issuance.
3. File the completed review checklist with the report (Annexure-1).

6. Abbreviations

• AMD: Analytical Method Development
• QA: Quality Assurance
• OOS: Out-of-Specification
• OOT: Out-of-Trend
• ALCOA: Attributable, Legible, Contemporaneous, Original, Accurate

7. Documents

1. Pre-Report Review Checklist – Annexure-1
2. OOS/OOT Review Log – Annexure-2

8. References

• ICH Q2(R1): Validation of Analytical Procedures
• 21 CFR Part 211: cGMP for Finished Pharmaceuticals
• MHRA GxP Data Integrity Guidance

9. SOP Version

Version: 2.0

10. Approval Section

11. Annexures

Annexure-1: Pre-Report Review Checklist

Checklist includes: raw data presence, sample ID verification, chromatogram quality, instrument log review, calculation correctness, correction justification, reviewer comments.

Annexure-2: OOS/OOT Review Log

Revision History:

Standard Operating Procedure for Verification of Analytical Calculations in AMD

1. Purpose

This SOP outlines the methodology for verifying analytical calculations used in the development, validation, and transfer of analytical methods to ensure reliability, accuracy, and compliance with applicable regulatory standards.

2. Scope

This procedure applies to all personnel in the Analytical Method Development (AMD) department involved in performing and verifying manual or electronic calculations related to assay, dissolution, content uniformity, stability testing, and impurity profiling.

3. Responsibilities

• Analyst: Performs analytical calculations and records results clearly in the worksheet.
• Reviewer/Scientist: Independently verifies all calculations for correctness and consistency.
• QA Personnel: Audits selected calculations during routine QA review or during validation report evaluation.

4. Accountability

The Head of AMD is responsible for ensuring proper verification of analytical calculations, availability of approved calculation templates, and adherence to GMP and GLP requirements.

5. Procedure

5.1 Calculation Types to be Verified

1. Assay percentage calculations
2. Impurity percentage and related substance estimations
3. Content uniformity calculations (Mean, RSD, AV)
4. Dissolution results (% release, average, SD)
5. LOD/LOQ estimations
6. Calibration curve slope and correlation coefficient (r²)
7. Degradation product quantification during stability studies

5.2 Calculation Verification Methods

1. Use a validated calculator, Excel spreadsheet, or CDS-integrated tool for independent re-calculation.
2. Cross-verify each input used in the calculation such as:
   • Sample weight
   • Dilution factors
   • Area of test and standard
   • Potency of standard
3. Ensure units are consistently used and any conversions are correctly applied.

5.3 Documentation of Verification

1. Reviewer must initial and date the verification next to the original calculation.
2. If electronic spreadsheets are used:
   • Print and sign the spreadsheet
   • Reference the version number and template ID used
3. Attach recalculation evidence as Annexure-1 with the worksheet.

5.4 Handling of Calculation Errors

1. Any identified calculation discrepancy must be:
   • Investigated for potential impact on reported results
   • Documented using deviation format (Annexure-2)
   • Corrected using GMP-compliant data correction practices (e.g., single line strike-through, date, and signature)

5.5 Use of Approved Calculation Templates

1. Only use QA-reviewed and version-controlled Excel templates or software systems for routine calculations.
2. All templates should be stored in a central server with access control and change log.
3. Analyst must ensure current version is in use before performing calculations.

5.6 Periodic Review and Audit

1. QA to conduct periodic review of templates and calculation verification logs to ensure compliance.
2. AMD Head to schedule quarterly audit of 10% randomly selected analytical reports for calculation integrity.

6. Abbreviations

• RSD: Relative Standard Deviation
• AV: Acceptance Value
• LOD: Limit of Detection
• LOQ: Limit of Quantitation
• CDS: Chromatographic Data System

7. Documents

1. Calculation Verification Record – Annexure-1
2. Calculation Error Deviation Format – Annexure-2
3. Approved Template Master List – Annexure-3

8. References

• ICH Q2(R1) – Validation of Analytical Procedures
• 21 CFR Part 211 – GMP for Finished Pharmaceuticals
• GAMP 5 – A Risk-Based Approach to Compliant GxP Computerized Systems

9. SOP Version

Version: 2.0

10. Approval Section

11. Annexures

Annexure-1: Calculation Verification Record

Includes sample ID, type of calculation, original result, verified result, reviewer name, signature, and date.

Annexure-2: Calculation Error Deviation Format

Deviation log for recording any miscalculations identified, including cause, impact assessment, corrective action taken.

Annexure-3: Approved Template Master List

Controlled list of calculation templates with template ID, description, version, date of approval, and owner.

Revision History:

Standard Operating Procedure for Documentation of Chromatographic System Suitability Parameters

1. Purpose

The purpose of this SOP is to establish a consistent process for documenting chromatographic system suitability parameters, such as theoretical plates, tailing factor, resolution, and repeatability, during analytical method development and validation activities.

2. Scope

This SOP applies to all personnel performing HPLC, UPLC, or GC-based chromatographic analyses in the Analytical Method Development (AMD) laboratory, where system suitability tests (SST) are mandatory to ensure analytical system performance.

3. Responsibilities

• Analyst: Executes system suitability runs and records parameters as per method SOP.
• AMD Scientist: Verifies acceptability of SST results and authorizes method execution.
• QA Reviewer: Audits documentation for completeness and ensures compliance with regulatory standards.

4. Accountability

The Head of AMD is accountable for implementation and control of this SOP, ensuring all chromatographic SST data are properly reviewed, documented, and retained.

5. Procedure

5.1 Understanding System Suitability Tests

1. System suitability tests are conducted to verify that the analytical system is adequate for performing the intended analysis.
2. Parameters assessed typically include:
   • Theoretical plates (N)
   • Tailing factor (T)
   • Resolution (Rs)
   • Repeatability (%RSD of peak area or retention time)
3. Acceptance criteria must be predefined in the method SOP based on validation studies or pharmacopeial recommendations.

5.2 Preparation for Chromatographic Runs

1. Ensure the system (e.g., HPLC/UPLC/GC) is calibrated and qualified.
2. Use freshly prepared mobile phase and equilibrate the system as per method conditions.
3. Inject standard solution as defined and allow system stabilization if required.

5.3 Recording System Suitability Parameters

1. After successful injection of standards:
   • Extract chromatograms and system-generated parameters from the software.
   • Record the following manually or via electronic data:
     • Retention time (Rt)
     • Peak area
     • Tailing factor
     • Theoretical plates
     • Resolution between critical peaks
     • Baseline noise (if applicable)
2. Enter these parameters into the System Suitability Log Sheet (Annexure-1).

5.4 Evaluation of System Suitability

1. Compare recorded SST values against the method-specific acceptance criteria.
2. If any parameter fails to meet criteria:
   • Do not proceed with sample injections.
   • Notify AMD Scientist and initiate investigation as per SOP for OOS/OOT handling.
3. If parameters pass:
   • Document ‘System suitability criteria met’ on analytical worksheet.
   • Proceed with analysis of test samples.

5.5 Data Integrity and Audit Trail

1. All chromatographic data must be stored securely within validated CDS software.
2. Ensure audit trail captures all modifications and re-integrations.
3. Printouts or electronic records should include chromatograms and summary reports with SST values.

5.6 Review and Approval

1. AMD Scientist to review and sign off on SST data and analytical worksheet before submission to QA.
2. QA to verify SST documentation as part of batch release or validation packet review.

6. Abbreviations

• SST: System Suitability Test
• HPLC: High-Performance Liquid Chromatography
• GC: Gas Chromatography
• UPLC: Ultra Performance Liquid Chromatography
• RSD: Relative Standard Deviation

7. Documents

1. System Suitability Log Sheet – Annexure-1
2. Chromatographic Data Review Checklist – Annexure-2
3. Instrument Audit Trail Verification Log – Annexure-3

8. References

• ICH Q2(R1) – Validation of Analytical Procedures
• 21 CFR Part 211 – Current Good Manufacturing Practices
• USP General Chapter <621> – Chromatography

9. SOP Version

Version: 2.0

10. Approval Section

11. Annexures

Annexure-1: System Suitability Log Sheet

Template to record retention time, theoretical plates, resolution, tailing factor, and RSD for standard injections.

Annexure-2: Chromatographic Data Review Checklist

Checklist includes items such as proper labeling, complete chromatograms, SST values, injection sequence, and calibration curve verification.

Annexure-3: Instrument Audit Trail Verification Log

Record audit trail checks performed before and after analysis, including reviewer name, date, observations, and comments.

Revision History: